Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
27.3M
-
Shares change
-
-602K
-
Total reported value, excl. options
-
$1.73B
-
Value change
-
-$35.4M
-
Put/Call ratio
-
1.07
-
Number of buys
-
84
-
Number of sells
-
-72
-
Price
-
$63.33
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q1 2018
187 filings reported holding CNMD - CONMED Corp - Common Stock as of Q1 2018.
CONMED Corp - Common Stock (CNMD) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.3M shares
of 30.9M outstanding shares and own 88.21% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.56M shares), VANGUARD GROUP INC (2.41M shares), SCOPIA CAPITAL MANAGEMENT LP (2.17M shares), DIMENSIONAL FUND ADVISORS LP (2.07M shares), VICTORY CAPITAL MANAGEMENT INC (1.81M shares), Capital Research Global Investors (1.33M shares), Champlain Investment Partners, LLC (1.32M shares), GOLDMAN SACHS GROUP INC (887K shares), CRAMER ROSENTHAL MCGLYNN LLC (796K shares), and MACQUARIE GROUP LTD (796K shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.